Retinitis pigmentosa refers to a diverse group of hereditary diseases affecting two million people worldwide that lead to incurable blindness. As a common pathology, Retinitis pigmentosa (1, 2) is the result of diverse mutations in more than 44 genes expressed in rod photoreceptors (3); these then degenerate, causing loss of night vision. Subsequently, cone photoreceptors, which are responsible for color and high acuity daytime vision, progressively lose their photoreceptive outer segments, leading to overall blindness. Despite this loss of sensitivity, cone cell bodies remain present longer 3 than rods in both humans and animals (4-6), but it is not known whether these lightinsensitive cells can be reactivated or if information from them can still flow to downstream visual circuits (Fig. 1A) for a significant time window after the loss of photosensitivity (7).
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To restore light-evoked activity in light-insensitive cone photoreceptors we genetically targeted a light-activated chloride pump (8) (9) (10) , enhanced Natronomonas pharaonis halorhodopsin (eNpHR) (11, 12) , to photoreceptors by means of adenoassociated viruses (AAVs) (13, 14) . Light-activated chloride pumps are rational candidates for reactivating vertebrate photoreceptors as both eNpHR-expressing cells (12) and healthy photoreceptors hyperpolarize in response to increases in light intensity.
We selected two animal models of Retinitis pigmentosa for gene therapy, both of which lead to retinal degeneration (RD). Cnga3 -/-; Rho -/-double-knockout mice served as a model of slow forms of RD (s-RD mice) (15) , and Pde6b rd1 (also known as rd1) mice as a model of fast forms of RD (f-RD mice) (16). Targeted expression of eNpHR was accomplished using three cell-specific promoters ( Fig. 1B ): Human rhodopsin (hRHO) (17) ; human red opsin (hRO) (18) ; and mouse cone arrestin-3 (mCAR) (19) .
To assess the effectiveness and specificity of the promoters, we used eNpHR fused to enhanced yellow fluorescent protein (11) AAVs were used as controls throughout this study (Fig. S1 ). We selected the hRO and mCAR promoters for s-RD mice ( Fig. 2B-C) , and the mCAR promoter for f-RD mice ( Fig. 2F ), based on their ability to selectively drive expression of eNpHR-EYFP in a high percentage of cone photoreceptors ( Fig. S2-S3 ). 4 The lifespan of cones in RD mice defines the window of opportunity for reactivation. We therefore tested EYFP or EGFP expression driven by the mCAR promoter at different time points during retinal degeneration. Surprisingly, EYFP and EGFP expression lasted more than eight months (Fig. 3A, S4 , last tested f-RD at P264, and s-RD at P255), longer than opsin protein expression (~P95 (5) or between P21 and P110 (20) , and data not shown). We isolated these long-lasting AAV-transduced cells from f-RD retinas at different time points and verified their identity by analyzing their transcriptome (P110-P220, Fig. S5 ). Cone-specific genes were expressed in the isolated cells while markers of other retinal cell types were absent, suggesting that AAV-labeled cells are altered cones, even at later stages of degeneration. The fact that opsin mRNA remained, while the opsin protein didn't suggests translational down-regulation of opsins. We estimate that ~27 % of cones remain between P184 and P255 in s-RD, and ~25% between P182 and P264 in f-RD mice (Fig. 3A) .
We tested whether eNpHR drives cone light responses in RD retinas at an age (P53-P264, Table S1 ) when many (s-RD) (15) or all (f-RD) (20) rods have already died.
eNpHR-EYFP-expressing photoreceptors in s-RD and f-RD retinas displayed large (Fig. 3B, S6), sustained (Fig. 3C) , and significantly faster (Fig. 3D ) photocurrents than wildtype cones. The photocurrents peaked at 580 nm. Photoreceptors expressing only EGFP did not react to light. The magnitude of photocurrents in eNpHR-transduced s-RD and f-RD mice were similar (Fig. 3B) . The current size was independent of the holding voltage ( Fig. 3E) , a finding that is consistent with the view that the photocurrents are mediated by ion pumps (10) . Photocurrents and voltages were modulated across three logarithmic units of intensities (Fig. S6 ). In the absence of functional outer segments, which normally generate currents that depolarize photoreceptors in the dark, RD photoreceptors were expected to stay hyperpolarized. A hyperpolarized state would limit the ability of eNpHR currents to modulate synaptic transmission. However, the We next asked if basic forms of spatial processing were functional in the e-NpHRtransduced RD retinas. Lateral inhibition is a conserved feature of vertebrate retinas that is important for spatial contrast ("edge") enhancement. When spots of increasing sizes were presented to eNpHR-expressing RD retinas, the response magnitude of ganglion cells reached a maximum and then gradually decreased, a sign of lateral inhibition (21,
24) (Fig. 4C, S7). Lateral inhibition also results in ON-center OFF-surround responses
(21) that we were also able to observe in eNpHR-expressing RD retinas (Fig. S7 ).
Another example of spatial processing is the directional-selective responses of types of ganglion cells to motion stimuli (25) . The activity of directional selective ganglion cells is important for the optokinetic reflex (26) . When eNpHR-transduced RD retinas were stimulated with bars moving in different directions some ganglion cells responded preferentially to motion in a particular direction but produced little activity when the bar moved in the opposite direction (27) (Fig. 4D ). This response asymmetry suggests that the retinal circuit for directional selectivity is, at least partially, maintained in RD retinas.
The sensitivity of eNpHR to light is less than that of normal cones (Fig. 4E) , and while normal cones can adapt to different light intensities, eNpHR-driven cones have a fixed sensitivity range (see Supplementary Discussion). However, the sensitivity of ganglion cells to light was 1.7 log units higher than that of the eNpHR-expressing photoreceptors (Fig. 4E) , and the light levels required for eNpHR stimulation at 580 nm are below the limit allowed for safe radiation of the human eye according to the "2006
European directives on artificial optical radiation" (Fig. 4E ) (28) .
The slow and fast RD mouse models not only differ in the time course of photoreceptor degeneration, but also in the amount of light-driven activity present during development. s-RD mice have no light-sensitive rod-cone system during development (15) while f-RD mice lose the rod-cone function gradually, and are blind by four weeks of age (16). In the retina, the responses in eNpHR-activated s-RD and f-RD mice were similar, suggesting that the development of the tested retinal functions, like direction selectivity, may not require light-driven input from rods and cones. Light stimulation of the eyes resulted in visually evoked potentials in eNpHR-expressing f-RD mice but not in EGFP-transduced controls (P42-P118, Fig. S8 ). In contrast to the retina, we could not measure light-driven cortical activity in eNpHR-transduced s-RD mice.
We next evaluated whether light could induce behavioral changes in eNpHRtransduced mice. In dark-light box tests (29) , eNpHR-expressing f-RD and s-RD mice performed significantly better than the corresponding EGFP-expressing control groups (P44-P143, Fig. 5A ), and the increased performance depended on the illumination level (Fig. 5B ). In the optomotor reflex test (30) , only eNpHR-expressing f-RD mice performed better than EGFP-expressing control mice at a variety of drum speeds (P69-P153, Fig. 5C ). Wild-type ( Fig. S8 ) and f-RD responses both peaked at the same speed.
The optimum spatial frequency was higher for wild-type animals (0.26 cpd) compared to f-RD (0.13 cpd). These experiments demonstrated that resensitized photoreceptors are able to drive visually-guided behavior in f-RD and, to some extent, in s-RD mice.
To test for potential toxicity of eNpHR or the unmodified NpHR, we first compared the retinas of eNpHR-transduced wild-type mice (six weeks after AAV administration) with those of normal wild-type mice. The number of photoreceptors was similar in both conditions (Fig. S9) and, in addition to the light-induced spiking activity, ganglion cells in eNpHR-transduced wild-type retinas had a wider action spectrum, a 8 gain of function at longer wavelengths, than ganglion cells in uninjected wild-type retinas (Fig. S9 ). This suggests that both intrinsic opsins and eNpHR are at work. Next, we compared the retinas of transgenic mice expressing NpHR in photoreceptors under the control of a bovine rhodopsin promoter with wild-type retinas and found similar numbers of photoreceptors (at P140, Fig. S9 ). These results suggest that in the studied time window neither the unmodified NpHR nor eNpHR induce additional photoreceptor degeneration.
The translation of gene therapy achieved in mice to human subjects requires the use of promoters and AAV serotypes that drive photoreceptor-specific eNpHR expression in human retinas. We therefore tested our AAVs on human ex vivo retinal explants (Fig. 6A) , which we could keep in culture for 2-3 weeks. Due to this short time window and the relatively long period of time required to efficiently express eNpHR from AAVs, we had to use immunohistochemistry to visualize eNpHR-EYFP protein expression in the cultured human retinas. Of the three promoters, mCAR directed expression of eNpHR specifically in human photoreceptors (Fig. S10) . To reduce the time required to obtain robust eNpHR-EYFP expression, necessary for two-photon laser targeted electrophysiology, we inserted the mCAR-eNpHR construct into a lentiviral vector (31) (Fig. S10 ). Using this new vector, high levels of eNpHR expression were found specifically in human photoreceptors after only 1-2 days of incubation (Fig. 6B,   S10 ). Brightly labeled photoreceptors in the parafoveal region displayed photocurrents and photovoltages with spectral tuning reflecting eNpHR activation (Fig. 6C, S10 ). We could not measure any photocurrents from control human retinas, even at the time when the retina was isolated.
To find potential patients with Retinitis pigmentosa eligible for eNpHR-mediated restoration of visual functions, we screened a database (see Supplementary Discussion) which contained records of retinal images acquired by optical coherence tomography (OCT), Goldman visual field tests, multifocal electroretinograms (ERG), full field ERG, and visual acuity tests. We identified legally blind patients (data from one of whom are shown in Fig. 6 and Fig. S11 ) with no visible outer segments on OCT pictures, but cone cell bodies in the central region. These criteria may be used in the future for selecting patients who could benefit from this therapy.
In summary 
